bpc-157 safety human clinical data and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded bpc-157 human clinical trials evidence
Description
Live Lactobacillus acidophilus alleviates ulcerative colitis via the SCFAs/mitophagy/NLRP3 inflammasome axis
There is currently no strong evidence showing that BPC-157 significantly increases metabolism
The standard approach uses 0.25 to 0.5 mg daily via subcutaneous injection near the medial epicondyle for 4 to 8 weeks
Schulz R, Belle SH, Czaja SJ, McGinnis KA, Stevens A, Zhang S
Typically, treatment will be once each week for 2-6 weeks
Only bacteriostatic water from reputable sources ensures safety
